13D Filing: James E. Flynn and Nivalis Therapeutics Inc. (NVLS)

Page 14 of 16

Page 14 of 16 – SEC Filing

Item 7. Material to be Filed as Exhibits.

Item 7 is hereby amended by adding the
following:

Exhibit 99.3 Form of Support Agreement, dated as of April 17, 2017, between the Issuer
and the Funds (incorporated by reference to Exhibit 2.5 to the Current Report on Form 8-K filed by the Issuer on April 18, 2017)

Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)

Page 14 of 16